Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed the office of president of the Society for Cardiovascular Angiography and Interventions (SCAI) at the conclusion of the the society’s annual scientific sessions (SCAI 2021, 28 April–1 May, virtual).
With a career devoted to interventional cardiology and clinical research, Henry has published more than 550 manuscripts and book chapters. His research interests include interventional cardiology, acute myocardial infarction (AMI), and novel therapies for patients with refractory angina. He has served as principal investigator and steering committees of multiple large, multicentre research trials in acute myocardial infarction and refractory angina, SCAI said in a press release. Henry is the former chief of cardiology at Cedar Sinai Medical Center in Los Angeles, USA and is known as a pioneer in the treatment of Myocardial Infarction and Refractory Angina.
“It is a tremendous honour to serve as president of SCAI, particularly during a time where interventional cardiologists around the world are faced with great challenges in our approach to care and treatment for the patients we serve. I look forward to working with SCAI’s dynamic leaders and staff to ensure that our members have the resources and education they need to lead innovation on the teams they serve and further advance patient care,” Henry stated.
During his presidency, Henry will focus on implementing SCAI’s new strategic plan, the continued growth of SCAI’s committees and councils, the new SCAI journal, and ensuring members recover from the disruption of the COVID-19 pandemic and its effects on patients.
Henry received his medical degree from the University of California, San Francisco, USA and completed his internal medicine residency and chief residency at the University of Colorado Health Sciences Center, Denver, USA before completing his cardiology fellowship at the University of Minnesota, Minneapolis, USA.
